R
DOSE
vs
S
S&P TSX Composite Index (Canada)
Over the past 12 months, DOSE has underperformed S&P TSX Composite Index (Canada), delivering a return of -40% compared to the S&P TSX Composite Index (Canada)'s +29% growth.
Stocks Performance
DOSE vs S&P TSX Composite Index (Canada)
Performance Gap
DOSE vs S&P TSX Composite Index (Canada)
Performance By Year
DOSE vs S&P TSX Composite Index (Canada)
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Rapid Dose Therapeutics Corp
Glance View
Rapid Dose Therapeutics Corp. engages in the provision of proprietary drug delivery technologies. The company is headquartered in Burlington, Ontario. The company went IPO on 2018-12-17. The firm provides drug-delivery technologies. The firm also provides production and consultation to the nutraceutical, cannabis healthcare and pharmaceutical manufacturing industries. The company owns an oral fast-dissolving drug delivery system, QuickStrip, which is capable of releasing into the blood stream a list of pharmaceuticals, emulsified oils and over-the-counter medicines without being degraded or modified by first pass metabolism in the liver. Its QuickStrip Energy product delivers energizing caffeine. Its QuickStrip B12 product delivers vitamin B12 to user's system, assisting with metabolism and physical energy. Melatonin is its QuickStrip Sleep product that delivers melatonin to the user's system. The RDMx mixture is its formulation, which is processed using RDT production equipment.
